Literature DB >> 8106

Insulin and glucagon degradation by the kidney. II. Characterization of the mechanisms at neutral pH.

W C Duckworth.   

Abstract

Examination of insulin and glucagon degradation by rat kidney subcellular fractions revealed that most degrading activity was localized to the 100 000 X g pellet and 100 000 X g supernatant fractions. Further characterization of the degrading activities of the 100 000 X g pellet and supernatant suggested that three types of enzymatic activity were present at neutral pH. From the cytosol an enzyme with characteristics of the insulin glucagon protease of skeletal muscle was purified. This enzyme appeared to be responsible for insulin degradation by the kidney at physiological insulin concentrations. This enzyme also contributed to glucagon degradation but was not the most active mechanism for this. In the 100 000 X g pellet at least two separate enzymatic activities were present. One of these had properties consistent with those described for glutathione insulin transhydrogenase and appeared to be responsible for insulin degradation at high insulin concentration. The other enzyme was associated with the brush border and had properties consistent with the brush border neutral protease. This enzyme appeared responsible for glucagon degradation at both low and high substrate concentrations. An apparent marked synergism between the 100 000 X g pellet and the 100 000 X g supernatant was noted for insulin degradation at physiological insulin concentrations. Pellet glucagon-degrading activity and soluble insulin-degrading activity were necessary for this. The mechanism was found to be limited insulin degradation by the soluble enzyme resulting in both trichloroacetic acid-precipitable trichloroacetic acid-soluble fragments followed by further degradtion of the fragments by the glucagon-degrading enzyme resulting in an additional increase in trichloroacetic acid-soluble products.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 8106     DOI: 10.1016/0304-4165(76)90021-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.

Authors:  K Shii; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Factors influencing the handling of insulin by the isolated rat kidney.

Authors:  R Rabkin; A E Kitabchi
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

4.  Initial site of insulin cleavage by insulin protease.

Authors:  W C Duckworth; F B Stentz; M Heinemann; A E Kitabchi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

Review 5.  The renal metabolism of insulin.

Authors:  R Rabkin; M P Ryan; W C Duckworth
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

6.  Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.

Authors:  Ling Hinshaw; Ashwini Mallad; Chiara Dalla Man; Rita Basu; Claudio Cobelli; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-07       Impact factor: 4.310

7.  Solubilization of insulin binding and degrading activity from guinea pig kidneys.

Authors:  M Kasuga; T Tsushima; Y Akanuma; K Kosaka
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

8.  Glucagon metabolism in the rat.

Authors:  D S Emmanouel; J B Jaspan; A H Rubenstein; A H Huen; E Fink; A I Katz
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Insulin degradation by adipose tissue. Studies at several levels of cellular organization.

Authors:  B J Goldstein; J N Livingston
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

10.  Glucagon degradation by human mononuclear cells.

Authors:  G W Neal; S S Solomon; T P Shankar; W C Duckworth
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.